Main menu
Edison Group
  • Home
  • Equities

    Equities

    View All Equities

    Equities by Sector

    VolitionRx

    MCap

    USD76m

    Last close

    USD0.81

    ▲ 0.14 (20.90%)

    Canyon Resources

    MCap

    AUD262m

    Last close

    AUD0.19

    ▲ 0.02 (12.12%)

    Immix Biopharma

    MCap

    USD51m

    Last close

    USD1.82

    ▲ 0.12 (7.06%)

  • Sectors

    Sectors

  • Thematics

    Thematics

    View All Thematics

    Latest

  • Audiovisual

    Audiovisual

    View All Audiovisual

    Latest

e-therapeutics (LSE: ETX)

Last close As at 20/11/2024

10.03

▲ 0.08 (0.80%)

Market capitalisation

59m

Edison Investment Research is terminating coverage on e-therapeutics (ETX). Please note you should no longer rely on any previous research or estimates for this company. All forecasts should now be considered redundant.

Latest Insights

View More

edison tv

Edison Growth Conference panel – Disruptive technology and AI

Healthcare | edison tv

e-therapeutics showcase

Healthcare | Update

e-therapeutics — More to come in RNAi therapy discovery

Healthcare | Initiation

e-therapeutics — Enhancing siRNA drug discovery with LLMs
e-therapeutics
Visit Website

Sector

Healthcare

Balance Sheet

Forecast net debt (£m)

N/A

Forecast gearing ratio (%)

N/A

Share Price Performance

Price Performance
% 1M 3M 12M
Actual (20.0) (39.3) (29.5)
Relative (21.3) (42.4) (29.6)
52 week high/low 23.1p/8.1p

Financials

Edison Investment Research is terminating coverage on ABC Arbitrage (ABCA), paragon (PGN), Foresight Solar Fund (FSFL), Kendrion (KENDR), Lithium Power International (LPI), Triple Point Energy Transition (TENT), 4iG (4IG), e-therapeutics (ETX), Pharnext (ALPHA) and Shield Therapeutics (STX). Please note you should no longer rely on any previous research or estimates for this company. All forecasts should now be considered redundant.

Previously published reports can still be accessed via our website.

Y/E Jan Revenue (£m) EBITDA (£m) PBT (£m) EPS (fd) (p) P/E (x) P/CF (x)
2022A 0.5 (9.4) (9.5) (1.65) N/A N/A
2023A 0.5 (9.8) (9.8) (1.54) N/A N/A
2024E N/A N/A N/A N/A N/A N/A
2025E N/A N/A N/A N/A N/A N/A

Research

edison tv

Healthcare

e-therapeutics showcase
e-therapeutics

Update

Healthcare

e-therapeutics — More to come in RNAi therapy discovery

edison tv

Edison Growth Conference panel – Disruptive technology and AI

Initiation

Healthcare

e-therapeutics — Enhancing siRNA drug discovery with LLMs

Thematics

Subscribe to Edison

Get access to the very latest content matched to your personal investment style.

Sign up for free